Operating Expenses - BioNote Inc (KRX:377740) - Alpha Spread
B

BioNote Inc
KRX:377740

Watchlist Manager
BioNote Inc
KRX:377740
Watchlist
Price: 4 595 KRW 0.33% Market Closed
Market Cap: 468.1B KRW
Have any thoughts about
BioNote Inc?
Write Note

BioNote Inc
Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

BioNote Inc
Operating Expenses Peer Comparison

Comparables:
068270
302440
H
145020
P
214450
196170

Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
B
BioNote Inc
KRX:377740
Operating Expenses
-â‚©35.5B
CAGR 3-Years
-18%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Celltrion Inc
KRX:068270
Operating Expenses
-â‚©816.5B
CAGR 3-Years
-32%
CAGR 5-Years
-29%
CAGR 10-Years
-23%
SK Bioscience Co Ltd
KRX:302440
Operating Expenses
-â‚©154.2B
CAGR 3-Years
-39%
CAGR 5-Years
-45%
CAGR 10-Years
N/A
H
Hugel Inc
KOSDAQ:145020
Operating Expenses
-â‚©124.1B
CAGR 3-Years
-17%
CAGR 5-Years
-16%
CAGR 10-Years
N/A
P
PharmaResearch Co Ltd
KOSDAQ:214450
Operating Expenses
-â‚©108.8B
CAGR 3-Years
-32%
CAGR 5-Years
-29%
CAGR 10-Years
N/A
Alteogen Inc
KOSDAQ:196170
Operating Expenses
-â‚©42.7B
CAGR 3-Years
-16%
CAGR 5-Years
-28%
CAGR 10-Years
N/A

See Also

What is BioNote Inc's Operating Expenses?
Operating Expenses
-35.5B KRW

Based on the financial report for Dec 31, 2023, BioNote Inc's Operating Expenses amounts to -35.5B KRW.

What is BioNote Inc's Operating Expenses growth rate?
Operating Expenses CAGR 3Y
-18%

Over the last year, the Operating Expenses growth was 22%. The average annual Operating Expenses growth rates for BioNote Inc have been -18% over the past three years .

Back to Top